ADVANCED MALIGNANT TUMOUR
Clinical trials for ADVANCED MALIGNANT TUMOUR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMOUR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMOUR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets hard-to-treat cancers with KRAS mutation in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug, HRS-7058, in adults with advanced solid tumors that have a specific KRAS G12C mutation. The main goals are to check the drug's safety, find the right dose, and see if it shrinks tumors. About 233 participants will receive the drug, an…
Matched conditions: ADVANCED MALIGNANT TUMOUR
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug called HRS-7058 combined with other cancer drugs in people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the combination is safe and can shrink tumors. About 300 adults aged 18 to 75 with good perfor…
Matched conditions: ADVANCED MALIGNANT TUMOUR
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:04 UTC